Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.750
+0.510 (12.03%)
Jun 29, 2026, 4:00 PM EDT - Market closed
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $284.43 million as of June 29, 2026. Its market cap has increased by 134.94% in one year.
Market Cap
284.43M
Enterprise Value
205.88M
1-Year Change
134.94%
Ranking
Category
Stock Price
$4.75
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $284.43M, an increase of 44.06%. That is a compound annual growth rate of 6.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 284.43M | 21.38% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Niagen Bioscience | 272.95M |
| Armata Pharmaceuticals | 271.66M |
| Lyell Immunopharma | 270.91M |
| Invivyd | 262.70M |
| Nautilus Biotechnology | 254.16M |
| AC Immune | 253.95M |
| Fulcrum Therapeutics | 253.21M |
| Foghorn Therapeutics | 247.77M |